Anja Meißner

2.0k total citations
50 papers, 1.5k citations indexed

About

Anja Meißner is a scholar working on Molecular Biology, Neurology and Immunology. According to data from OpenAlex, Anja Meißner has authored 50 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 14 papers in Neurology and 11 papers in Immunology. Recurrent topics in Anja Meißner's work include Sphingolipid Metabolism and Signaling (14 papers), Neuroinflammation and Neurodegeneration Mechanisms (11 papers) and Neurological Disease Mechanisms and Treatments (5 papers). Anja Meißner is often cited by papers focused on Sphingolipid Metabolism and Signaling (14 papers), Neuroinflammation and Neurodegeneration Mechanisms (11 papers) and Neurological Disease Mechanisms and Treatments (5 papers). Anja Meißner collaborates with scholars based in Germany, Sweden and Spain. Anja Meißner's co-authors include Heinrich Körner, Uwe Ritter, Anna M. Planas, Karlheinz Friedrich, Francesc Miró‐Mur, Udo R. Markert, Darcy Lidington, Steffen-Sebastian Bolz, Jeffrey T. Kroetsch and Carles Justicia and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Anja Meißner

47 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anja Meißner Germany 23 475 387 212 173 158 50 1.5k
Joaquín Fernández‐Irigoyen Spain 25 730 1.5× 277 0.7× 200 0.9× 225 1.3× 366 2.3× 140 2.0k
Enrique Santamaría Spain 25 864 1.8× 276 0.7× 203 1.0× 231 1.3× 409 2.6× 146 2.2k
Xue Ma China 29 988 2.1× 321 0.8× 157 0.7× 83 0.5× 169 1.1× 96 2.1k
Weihong Zhou China 26 1.2k 2.4× 434 1.1× 133 0.6× 174 1.0× 282 1.8× 76 2.5k
Ranran Wang China 24 1.0k 2.1× 432 1.1× 273 1.3× 114 0.7× 69 0.4× 64 2.0k
Nicole L. Stone United States 20 727 1.5× 283 0.7× 115 0.5× 44 0.3× 143 0.9× 44 3.4k
R Joseph United States 23 691 1.5× 365 0.9× 118 0.6× 61 0.4× 120 0.8× 65 1.6k
Peter Findeisen Germany 26 745 1.6× 239 0.6× 87 0.4× 52 0.3× 127 0.8× 88 1.9k
Xiaoqiang Wang China 27 1.6k 3.5× 199 0.5× 94 0.4× 178 1.0× 186 1.2× 151 3.0k
Stephen T. Yeung United States 18 680 1.4× 779 2.0× 363 1.7× 76 0.4× 444 2.8× 36 1.9k

Countries citing papers authored by Anja Meißner

Since Specialization
Citations

This map shows the geographic impact of Anja Meißner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anja Meißner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anja Meißner more than expected).

Fields of papers citing papers by Anja Meißner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anja Meißner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anja Meißner. The network helps show where Anja Meißner may publish in the future.

Co-authorship network of co-authors of Anja Meißner

This figure shows the co-authorship network connecting the top 25 collaborators of Anja Meißner. A scholar is included among the top collaborators of Anja Meißner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anja Meißner. Anja Meißner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Piani, Federica, et al.. (2025). Sphingosine-1-Phosphate, a Marker of Endothelial Injury and Disease Severity in Preeclampsia. Hypertension. 82(5). 914–925.
3.
Jujić, Amra, Peter M. Nilsson, Ulf Lindblad, et al.. (2023). Plasma Galectin-4 Levels Are Increased after Stroke in Mice and Humans. International Journal of Molecular Sciences. 24(12). 10064–10064. 2 indexed citations
4.
Nieto‐Fontarigo, Juan José, Samuel Cerps, Sangeetha Ramu, et al.. (2023). C57Bl/6N mice have an attenuated lung inflammatory response to dsRNA compared to C57Bl/6J and BALB/c mice. Journal of Inflammation. 20(1). 6–6. 5 indexed citations
5.
Matthes, Frank, et al.. (2023). Ivacaftor therapy post myocardial infarction augments systemic inflammation and evokes contrasting effects with respect to tissue inflammation in brain and lung. Biomedicine & Pharmacotherapy. 162. 114628–114628. 2 indexed citations
6.
Lidington, Darcy, Franziska E. Uhl, João M. N. Duarte, et al.. (2022). Restoring myocardial infarction-induced long-term memory impairment by targeting the cystic fibrosis transmembrane regulator. EBioMedicine. 86. 104384–104384. 9 indexed citations
7.
Uhl, Franziska E., et al.. (2022). Cystic fibrosis transmembrane regulator correction attenuates heart failure-induced lung inflammation. Frontiers in Immunology. 13. 928300–928300. 6 indexed citations
8.
Jujić, Amra, Frank Matthes, Marju Orho‐Melander, et al.. (2021). Plasma S1P (Sphingosine-1-Phosphate) Links to Hypertension and Biomarkers of Inflammation and Cardiovascular Disease: Findings From a Translational Investigation. Hypertension. 78(1). 195–209. 23 indexed citations
9.
Matthes, Frank, et al.. (2021). Simvastatin therapy attenuates memory deficits that associate with brain monocyte infiltration in chronic hypercholesterolemia. SHILAP Revista de lepidopterología. 7(1). 19–19. 6 indexed citations
10.
Salas-Perdomo, Angélica, Francesc Miró‐Mur, Mattia Gallizioli, et al.. (2019). Role of the S1P pathway and inhibition by fingolimod in preventing hemorrhagic transformation after stroke. Scientific Reports. 9(1). 8309–8309. 136 indexed citations
11.
Wang, Wei, Björn Sigurðsson, Abdellatif Benraiss, et al.. (2019). PDGF-B Is Required for Development of the Glymphatic System. Cell Reports. 26(11). 2955–2969.e3. 103 indexed citations
12.
Meißner, Anja, et al.. (2016). Sphingosine-1-phosphate signalling—a key player in the pathogenesis of Angiotensin II-induced hypertension. Cardiovascular Research. 113(2). 123–133. 46 indexed citations
13.
Meißner, Anja. (2016). Hypertension and the Brain: A Risk Factor for More Than Heart Disease. Cerebrovascular Diseases. 42(3-4). 255–262. 113 indexed citations
14.
Teitelbaum, Aaron M., et al.. (2013). Synthesis, pH-dependent, and plasma stability of meropenem prodrugs for potential use against drug-resistant tuberculosis. Bioorganic & Medicinal Chemistry. 21(17). 5605–5617. 24 indexed citations
16.
Hoefer, Judith, Mohammed Ali Azam, Jeffrey T. Kroetsch, et al.. (2010). Sphingosine-1-Phosphate–Dependent Activation of p38 MAPK Maintains Elevated Peripheral Resistance in Heart Failure Through Increased Myogenic Vasoconstriction. Circulation Research. 107(7). 923–933. 62 indexed citations
17.
Kesenheimer, Christian, et al.. (2010). The Cobalt Way to Angucyclinones: Asymmetric Total Synthesis of the Antibiotics (+)‐Rubiginone B2, (−)‐Tetrangomycin, and (−)‐8‐O‐Methyltetrangomycin. Chemistry - A European Journal. 16(29). 8805–8821. 24 indexed citations
18.
Wiede, Florian, et al.. (2005). TNF but not Fas ligand provides protective anti-L. major immunity in C57BL/6 mice. Microbes and Infection. 7(15). 1461–1468. 14 indexed citations
19.
Fitzgerald, J.S., Anja Meißner, Tobias Wengenmayer, et al.. (2005). Trophoblast invasion: tuning through LIF, signalling via Stat3. Placenta. 26. S37–S41. 95 indexed citations
20.
Fitzgerald, Justine S., Tobias G. Poehlmann, Luciana Berod, et al.. (2005). Leukemia inhibitory factor triggers activation of signal transducer and activator of transcription 3, proliferation, invasiveness, and altered protease expression in choriocarcinoma cells. The International Journal of Biochemistry & Cell Biology. 37(11). 2284–2296. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026